SCHEMBL17784180

SCHEMBL17784180

CCCCOC(=O)c1ccc(Nc2nc(Nc3ccc(C(=O)OCCCC)cc3)nc(Nc3ccc(C(=O)OCCCC)cc3)n2)cc1.c1cnnnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.55
RECQL P46063 1/20 0.55
ALDH1A1 P00352 4/20 0.54
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
KDM4E B2RXH2 1/20 0.54
NPC1 O15118 1/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
THRB P10828 1/20 0.53
MAPT P10636 6/20 0.53
TP53 P04637 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 2/20 0.51
CYP1A2 P05177 2/20 0.51
TSHR P16473 2/20 0.51
CYP2C19 P33261 2/20 0.51
MAPK1 P28482 2/20 0.51
ESR1 P03372 1/20 0.51
CYP2D6 P10635 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20787721 0.86 HPGD (0.59) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL12896253 0.86 MAPT (0.61) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL12896256 0.86 MAPT (0.61) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL12462983 0.85 HPGD (0.58) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL4772394 0.85 RAB9A (0.65) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL16385836 0.84 SMN1; SMN2 (0.61) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL14160684 0.84 LMNA (0.57) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL17212256 0.84 HPGD (0.56) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL12727778 0.84 HPGD (0.56) HPGDRECQLALDH1A1RAB9ASMN1; SMN2
SCHEMBL10940888 0.81 HPGD (0.74) HPGDRECQLALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045409-B2 Composition comprising a water-insoluble solid organic UV-screening agent and a compound capable of establishing hydrogen bonds L'OREAL (FR) 2021-06-29 US disclosed
US-20160151267-A1 COMPOSITION COMPRISING A WATER-INSOLUBLE SOLID ORGANIC UV-SCREENING AGENT AND A COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS L'OREAL (FR) 2016-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160151267-A1 COMPOSITION COMPRISING A WATER-INSOLUBLE SOLID ORGANIC UV-SCREENING AGENT AND A COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS F2, F12, C1S HPGD 312/4885RECQL 112/4885ALDH1A1 1323/4885
US-11045409-B2 Composition comprising a water-insoluble solid organic UV-screening agent and a compound capable of establishing hydrogen bonds F2, F12, C1S HPGD 312/4885RECQL 112/4885ALDH1A1 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.